Moffitt Cancer Center

Stand Up To Cancer awards Moffitt $2.67M to study lung cancer immunotherapy

Friday, October 13, 2017

Moffitt Cancer Center was awarded a $2.67 million grant from Stand Up To Cancer (SU2C) to study a possible new immunotherapy for non-small cell lung cancer. This is one of 10 first-of-its-kind grants being awarded by the SU2C Catalyst program. Under the program, pharmaceutical companies donate funds to support collaborative team research using products provided by the companies, such as compounds and agents in development or approved for investigational use. The Moffitt study will be in partnership with Bristol-Myers Squibb, with additional assistance from Iovance and Prometheus Laboratories.

[Read More]

Moffitt, The US Oncology Network advance cancer patient services

Thursday, October 27, 2011

Moffitt Cancer Center,  the only National Cancer Institute(NCI) Comprehensive Cancer Center in Florida, and The US Oncology Network will work together to expand access to patient services in Florida. As part of both organizations’ long-term commitment to advancing the quality and science of cancer care, the two are collaborating to develop and operate community-based cancer centers throughout the state.

[Read More]